PTX 2.50% 3.9¢ prescient therapeutics limited

Ann: Former Juno Executive Joins Prescient Board, page-4

ANNOUNCEMENT SPONSORED BY PLUS500
ANNOUNCEMENT SPONSORED BY PLUS500
CFD TRADING PLATFORM
CFD Service. Your Capital is at risk
CFD TRADING PLATFORM CFD Service. Your Capital is at risk
ANNOUNCEMENT SPONSORED BY PLUS500
CFD TRADING PLATFORM CFD Service. Your Capital is at risk
  1. 2,466 Posts.
    lightbulb Created with Sketch. 354
    This is another feather in PTX's hat. Building on internal capabilities that will help leverage the technology and research that is happening behind the scenes.

    Dr Ebens looks like (on paper at least) to potentially have contacts in the US to partner with further as advancements are made and progress on trials are reached.

    I think we're at a pivoting point for PTX as they develop their OmniCAR platform further and build on their internal skills and knowledge to gain a competitive advantage and commercialise their products.

    Well done PTX team, looking forward to further trial announcements.
 
watchlist Created with Sketch. Add PTX (ASX) to my watchlist
(20min delay)
Last
3.9¢
Change
-0.001(2.50%)
Mkt cap ! $31.40M
Open High Low Value Volume
4.1¢ 4.1¢ 3.9¢ $72.73K 1.802M

Buyers (Bids)

No. Vol. Price($)
5 436541 3.9¢
 

Sellers (Offers)

Price($) Vol. No.
4.1¢ 560576 1
View Market Depth
Last trade - 15.59pm 15/11/2024 (20 minute delay) ?
PTX (ASX) Chart
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.